News – Advanced BioDesign

Press Releases

Advanced BioDesign joins forces with GTP Bioways to startmanufacturing of its innovative treatment for Acute MyeloidLeukemia (AML)

27 mars 2024

Lyon, Toulouse (France), March 27, 2024 – Advanced BioDesign, a biotech company specializing in the development of new therapeutic approaches to resistant cancers, and GTP…
Advanced BioDesign, winner of the France 2030 plan’s call for « i-DEMO » projects to finance its « Odyssey » clinical trial with up to €3M

24 juillet 2023

Advanced BioDesign’s winning project is its first-in-human clinical trial of its drug candidate ABD-3001 for patients with acute myeloid leukaemia (AML) who are resistant to…